Drug intelligence / Profile preview

pyrroloquinoline quinone disodium

Development stage
Unknown
Lead developer
Mitsubishi Gas Chemical
Modality
Small Molecules
Administration
Oral
01

Overview

Pyrroloquinoline quinone (PQQ) disodium is a salt form of the redox-active cofactor PQQ, which is being investigated for its potential anti-aging and neuroprotective properties. It acts as a cofactor for several enzymes and is known to stimulate mitochondrial biogenesis, primarily through the activation of the PGC-1α pathway and modulation of Sirtuin 1 (Sirt1). In clinical research, such as the study conducted by The First People's Hospital of Kunshan (ChiCTR2500103910), PQQ disodium is evaluated for its ability to increase NAD+ levels, enhance antioxidant defenses by increasing superoxide dismutase (SOD) activity, and reduce oxidative damage as measured by malondialdehyde (MDA) levels. It is commonly available as a dietary supplement and is studied for its effects on fatigue and cognitive function.

Brand names
BioPQQ
Other names
PQQ disodium saltPQQ-Na2PQQ-Na-2PQQ-Na 2methoxatin disodium saltpyrroloquinoline quinone sodium saltPQQpyrroloquinoline quinonemethoxatin
02

Targets

PPARGC1A (Peroxisome proliferator–activated receptor gamma coactivator 1-alpha)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)Misfolded SOD1

Beyond the preview

Go deeper on pyrroloquinoline quinone disodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pyrroloquinoline quinone disodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call